Clinical trials are evolving. So should your central lab.
Today's clinical trials are more complex than ever before—from accelerated timelines and increasing endpoints to harder-to-reach patients and a shift to non-traditional countries.
To better understand these challenges and the role a central lab should play in solving them, we surveyed more than 100 global biopharma leaders at large, mid-sized and emerging companies.
In this report, we've compiled key feedback on how central labs are uniquely positioned to drive change across key trends:
- Break down silos through stronger collaboration
- Enhance data aggregation and insight sharing
- Provide more region-specific support
- Rapidly deliver quality and consistency across global sites
- Integrate holistic solutions to reduce trial complexity